Clinical Efficacy and Safety of Tevagrastim® (XM02), a Biosimilar Recombinant Human Granulocyte Colony-Stimulating Factor
Biosimilars
doi 10.2147/bs.s27712
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2013
Authors
Publisher
Informa UK Limited